Cargando…

Ifosfamide ±VP16 in Childhood' Malignancy: A Phase II (toxicity) Study

Detalles Bibliográficos
Autores principales:	Pizer, B., Oakhill, A., Mott, M. G., Sleight, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Clinical Press 1988
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113656/ https://www.ncbi.nlm.nih.gov/pubmed/28906801

Ejemplares similares

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies
por: Hamberg, P, et al.
Publicado: (2010)

Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
por: Marx, G, et al.
Publicado: (2002)

Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
por: Kosmas, C, et al.
Publicado: (2003)

OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS
por: Winzent, Shelby, et al.
Publicado: (2020)

Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report
por: Cheung, Michelle CM, et al.
Publicado: (2011)

Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney
por: Han, Hyoung-Yun, et al.
Publicado: (2021)

Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
Publicado: (1998)

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.
por: Pronk, L. C., et al.
Publicado: (1998)

Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study
por: Morgan, Jessica E., et al.
Publicado: (2016)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors
por: Hirbe, Angela C., et al.
Publicado: (2017)

Phase II Study of Ifosfamide+Doxorubicin in Patients With Advanced Synovial Sarcomas (E1793): A Trial of the Eastern Cooperative Oncology Group
por: Edmonson, John H., et al.
Publicado: (2003)

CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
por: KÃ¶ppler, H., et al.
Publicado: (1989)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
por: Kerbusch, T, et al.
Publicado: (2004)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011)

Structure of the VP16 Transactivator Target in ARC/Mediator
por: Milbradt, Alexander G., et al.
Publicado: (2011)

Effective Treatment of a Malignant Breast Phyllodes Tumor with Doxorubicin-Ifosfamide Therapy
por: Yamamoto, Shinya, et al.
Publicado: (2019)

The Role of VP16 in the Life Cycle of Alphaherpesviruses
por: Fan, Dengjian, et al.
Publicado: (2020)

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study
por: Scinto, A F, et al.
Publicado: (1999)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Host factors associated with either VP16 or VP16‐induced complex differentially affect HSV‐1 lytic infection
por: Ding, Xiuyan, et al.
Publicado: (2022)

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
por: Kosmas, C, et al.
Publicado: (2011)

Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells.
por: Gantchev, T. G., et al.
Publicado: (1996)

The assessment of in vivo somatic mutations in survivors of childhood malignancy.
por: Hewitt, M., et al.
Publicado: (1992)

Effect of Berberis vulgaris L. root extract on ifosfamide-induced in vivo toxicity and in vitro cytotoxicity
por: Ilyas, Shazia, et al.
Publicado: (2021)

Cyclosporin A and doxorubicin-ifosfamide in resistant solid tumours: a phase I and an immunological study.
por: González-Manzano, R., et al.
Publicado: (1995)

Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor
por: Provenzano, Salvatore, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

Karyomegalic interstitial nephropathy following ifosfamide therapy
por: Jayasurya, R., et al.
Publicado: (2016)

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
por: Kosmas, C, et al.
Publicado: (2000)

Outcome and Toxicity of an Ifosfamide-Based Soft Tissue Sarcoma Treatment Protocol in Children. The Importance of Local Therapy
por: Yule, S. Murray, et al.
Publicado: (1998)

Crystallization and preliminary crystallographic analysis of the major capsid proteins VP16 and VP17 of bacteriophage P23-77
por: Rissanen, Ilona, et al.
Publicado: (2012)

Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides
por: Duca, Maria, et al.
Publicado: (2006)

Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer
por: Fujita, A, et al.
Publicado: (2003)

Comparative Proteomic and Morpho-Physiological Analyses of Maize Wild-Type Vp16 and Mutant vp16 Germinating Seed Responses to PEG-Induced Drought Stress
por: Liu, Songtao, et al.
Publicado: (2019)

Possible metabolic interaction between docetaxel and ifosfamide
por: Ando, Y
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_2em41uf56k5h4umcfdl5c9av5l